Ton Logtenberg
Presidente presso Synox Therapeutics Ltd.
Posizioni attive di Ton Logtenberg
Società | Posizione | Inizio | Fine |
---|---|---|---|
Utrecht Science Park | Direttore/Membro del Consiglio | 01/11/2014 | - |
Jenner Vaccine Foundation | Direttore/Membro del Consiglio | 01/01/2008 | - |
Hubrecht Organoid Technology Foundation | Direttore/Membro del Consiglio | 01/08/2018 | - |
Synox Therapeutics Ltd.
Synox Therapeutics Ltd. BiotechnologyHealth Technology Synox Therapeutics Ltd. a clinical stage biopharmaceutical company. The company is headquartered in Dublin, Ireland. | Presidente | 27/07/2021 | - |
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investitore di Private Equity | 31/03/2022 | - |
Mestag Therapeutics Ltd.
Mestag Therapeutics Ltd. Financial ConglomeratesFinance Mestag Therapeutics Ltd. is engaged in the biotechnology industry. The company was founded on February 17, 2020 and is headquartered in Cambridge, the United Kingdom. | Presidente | 20/12/2022 | - |
Direttore/Membro del Consiglio | 01/01/2022 | 20/12/2022 |
Storia della carriera di Ton Logtenberg
Precedenti posizioni note di Ton Logtenberg
Società | Posizione | Inizio | Fine |
---|---|---|---|
MERUS N.V. | Direttore/Membro del Consiglio | 16/06/2003 | 31/12/2019 |
Amministratore Delegato | 16/06/2003 | 31/12/2019 | |
Direttore Finanziario/CFO | - | 31/12/2019 | |
Fondatore | 16/06/2003 | 31/12/2019 | |
Presidente | 16/06/2003 | 31/12/2019 | |
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Direttore Tecnico/Scientifico/R&S | 01/07/2000 | 01/11/2003 |
Fondatore | 01/07/2000 | 01/11/2003 | |
FORN EUROPAR | Direttore/Membro del Consiglio | - | - |
Independent Dir/Board Member | - | - | |
░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formazione di Ton Logtenberg
University of Utrecht | Doctorate Degree |
Statistiche
Distribuzione geografica
Paesi Bassi | 7 |
Regno Unito | 3 |
Irlanda | 2 |
Posizioni
Director/Board Member | 6 |
Founder | 2 |
Chairman | 2 |
Settori
Health Technology | 4 |
Finance | 4 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
MERUS N.V. | Health Technology |
Aziende private | 8 |
---|---|
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Health Technology |
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Finance |
Jenner Vaccine Foundation | |
Utrecht Science Park | |
Hubrecht Organoid Technology Foundation | |
Mestag Therapeutics Ltd.
Mestag Therapeutics Ltd. Financial ConglomeratesFinance Mestag Therapeutics Ltd. is engaged in the biotechnology industry. The company was founded on February 17, 2020 and is headquartered in Cambridge, the United Kingdom. | Finance |
Synox Therapeutics Ltd.
Synox Therapeutics Ltd. BiotechnologyHealth Technology Synox Therapeutics Ltd. a clinical stage biopharmaceutical company. The company is headquartered in Dublin, Ireland. | Health Technology |
Forbion European Acquisition Corp.
Forbion European Acquisition Corp. Financial ConglomeratesFinance Forbion European Acquisition Corp. is a blank check company. It engages in the business of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was founded by Hugo Alexander Slootweg in 2006 and is headquartered in Wilmington, DE. | Finance |
- Borsa valori
- Insiders
- Ton Logtenberg
- Esperienza